Ignacio Muñoz-Sanjuan

Title: Ignacio Muñoz-Sanjuan: Innovator in Pharmaceutical Research

Introduction

Ignacio Muñoz-Sanjuan is a notable inventor based in West Hollywood, CA. He has made significant contributions to the field of pharmaceutical research, particularly in the development of treatments for neurodegenerative disorders.

Latest Patents

Ignacio holds a patent for "Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof." This patent includes certain chemical entities that are designed to inhibit KMO activity. The pharmaceutical compositions described in the patent comprise at least one chemical entity and one or more pharmaceutically acceptable vehicles. The methods outlined in the patent focus on treating patients suffering from diseases responsive to KMO inhibition, including Huntington's disease. The patent also details methods for screening compounds capable of inhibiting KMO activity.

Career Highlights

Ignacio is currently associated with the Chdi Foundation, Inc., where he continues to advance his research in the pharmaceutical sector. His work is pivotal in developing innovative treatments that address critical health issues.

Collaborations

Ignacio has collaborated with esteemed colleagues such as Stephen Martin Courtney and Michael Edward Prime, contributing to a dynamic research environment.

Conclusion

Ignacio Muñoz-Sanjuan's work in pharmaceutical innovations highlights his commitment to improving treatments for neurodegenerative disorders. His contributions are essential in the ongoing quest for effective therapies.